Caribou Biosciences, Inc. (CRBU)

Caribou Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	11.14	16.29	51.16	58.34	240.42	15.95
Short-Term Investments	136.12	193.24	277.67	189.33	135.41	-
Cash & Short-Term Investments	147.26	209.54	328.83	247.66	375.83	15.95
Cash Growth	-35.46%	-36.28%	32.77%	-34.10%	2255.87%	-67.75%
Accounts Receivable	1.1	1.42	1.57	2.45	2.64	1.48
Other Receivables	1.83	1.83	2.29	2.22	5.48	3.68
Receivables	2.93	3.25	3.86	4.66	8.12	5.16
Prepaid Expenses	1.93	4.81	4.94	6.37	3.85	1.82
Other Current Assets	3.39	1.78	1.22	1.55	3.39	1.38
Total Current Assets	155.51	219.38	338.84	260.25	391.19	24.31
Property, Plant & Equipment	23.6	39.29	40.45	34.91	4.89	3.5
Long-Term Investments	12.1	49.13	51.33	77.07	45.3	7.63
Other Long-Term Assets	3.78	5.52	1.59	1.54	0.98	0.61
Total Assets	194.98	313.31	432.21	373.77	442.36	36.05
Accounts Payable	3.8	2.48	3.12	1.15	3.99	2.6
Accrued Expenses	17.49	21.94	19.65	14.41	12.09	8.15
Current Portion of Long-Term Debt	-	-	-	-	-	0.65
Current Portion of Leases	2.69	1.43	1.2	0.97	-	-
Current Unearned Revenue	2.22	3.13	2.85	9.94	8.7	0.16
Other Current Liabilities	1.86	1.68	1.48	1.67	1.05	0.82
Total Current Liabilities	28.06	30.65	28.3	28.13	25.83	12.39
Long-Term Debt	-	-	-	-	-	0.92
Long-Term Leases	22.78	25.06	25.91	26.78	-	0.1
Long-Term Unearned Revenue	1.76	3.32	6.1	15.95	22.03	0.94
Long-Term Deferred Tax Liabilities	0.55	0.55	0.56	0.38	0.48	0.16
Other Long-Term Liabilities	-	0.79	2.94	1.65	6.19	3.66
Total Liabilities	53.14	60.36	63.81	72.89	54.53	18.16
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	711.77	701.08	667.65	499.6	485.75	7.43
Retained Earnings	-570.03	-448.39	-299.29	-197.22	-97.79	-30.87
Comprehensive Income & Other	0.09	0.26	0.03	-1.52	-0.14	-
Total Common Equity	141.85	252.95	368.4	300.87	387.83	-23.44
Shareholders' Equity	141.85	252.95	368.4	300.87	387.83	17.89
Total Liabilities & Equity	194.98	313.31	432.21	373.77	442.36	36.05
Total Debt	25.46	26.49	27.11	27.75	-	1.68
Net Cash (Debt)	133.75	222.9	345.3	289.29	413.51	14.28
Net Cash Growth	-47.42%	-35.45%	19.36%	-30.04%	2796.73%	-71.03%
Net Cash Per Share	1.45	2.47	4.68	4.76	13.06	1.67
Filing Date Shares Outstanding	93.47	93	90.31	61.3	60.66	10.39
Total Common Shares Outstanding	93.47	92.38	88.45	61.03	60.26	9.71
Working Capital	127.45	188.73	310.54	232.12	365.36	11.92
Book Value Per Share	1.52	2.74	4.17	4.93	6.44	-2.41
Tangible Book Value	141.85	252.95	368.4	300.87	387.83	-23.44
Tangible Book Value Per Share	1.52	2.74	4.17	4.93	6.44	-2.41
Machinery	17.48	20.65	16.98	13.46	7.25	5.42
Construction In Progress	-	-	8.2	0.99	0.01	-
Leasehold Improvements	3.02	11.52	2.24	1.88	1.7	1.18

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q